The new plant is being built to facilitate upscaled manufacturing processes to meet the increasing global demand for the Versius surgical robotic system
Medical devices maker CMR Surgical has unveiled plans to build a new large-scale global manufacturing facility in Cambridgeshire, UK.
The new plant is being built to facilitate upscaled manufacturing processes to meet the increasing demand for the Versius surgical robotic system.
The robotic system is used in multiple hospitals across Europe, India, Australia and the Middle East.
CMR is focusing on the ongoing commercial scale-up of Versius and the building of its manufacturing capability following the recent completion of the MedTech private financing round worldwide.
The new facility, which will feature 7,044m² floor space, will employ around 200 skilled employees in various units such as production, quality, manufacturing engineering, supply, operations, and logistics.
CMR Surgical CEO Per Vegard Nerseth said: “We continue to see strong demand for Versius in markets around the world and our commitment to building a new manufacturing facility reflects this whilst highlighting the scale of our ambition to transform surgery.
“The workforce in Cambridgeshire will be crucial in helping us deliver systems to benefit patients in all corners of the world and we see this as an important development in our company growth strategy.”
The Versius system is designed to virtually fit into any operating room set-up, as well as integrate into existing workflows and increase the likelihood of robotic minimal access surgery.
Its portable and modular design enables the surgeon to only use the number of arms required for a given procedure.
Versius, bio-mimicking the human arm, allows surgeons for optimised port placement alongside the dexterity and accuracy of small fully-wristed instruments.
By offering 3D HD vision, easy-to-adopt instrument control and various working positions, the open surgeon console can minimise stress and fatigue and enables clear communication with the surgical team.
In June this year, CMR Surgical secured $600m in Series D financing to accelerate continued global expansion and commercial scale-up of the business.